Jialin Li
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Tolebrutinib in nonrelapsing SPMS: regulatory divergence and the limits of relapse based labels.
Journal: Multiple sclerosis and related disorders
Published: July 06, 2026
Assessment of chest CT abnormalities and pulmonary function at 6-month and 1-year after hospital discharge in Chinese patients of COVID-19 pneumonia at the turn of 2022-2023.
Journal: Frontiers in medicine
Published: July 11, 2024
Yueliang Yin Ameliorates Endometrial Receptivity in Mice with Embryo Implantation Failure by Reducing Pyroptosis and Activating BDNF/TrkB Pathway.
Journal: Molecular nutrition & food research
Published: May 24, 2023
Therapeutic mechanisms of mulberry leaves in type 2 diabetes based on metabolomics.
Journal: Frontiers in pharmacology
Published: June 09, 2022
Xiongshao Zhitong Recipe Attenuates Nitroglycerin-Induced Migraine-Like Behaviors via the Inhibition of Inflammation Mediated by Nitric Oxide Synthase.
Journal: Frontiers in pharmacology
Published: April 14, 2022
Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS via Inhibiting TLR4/NF-kB Pathway and NLRP3 Inflammasome Activation.
Journal: Frontiers in pharmacology
Published: October 06, 2021
A novel strategy to reveal clinical advantages and molecular mechanism of aidi injection in the treatment of pancreatic cancer based on network meta-analysis and network pharmacology.
Journal: Journal of ethnopharmacology
Published: August 25, 2021
Investigation on the Efficiency of Chinese Herbal Injections combined with Concurrent Chemoradiotherapy for Treating Nasopharyngeal Carcinoma based on Multidimensional Bayesian Network Meta-analysis.
Journal: Frontiers in pharmacology
Published: January 21, 2021
Dissecting the novel mechanism of reduning injection in treating Coronavirus Disease 2019 (COVID-19) based on network pharmacology and experimental verification.
Journal: Journal of ethnopharmacology
Published: January 03, 2021
Investigation on the mechanisms of guiqi huoxue capsule for treating cervical spondylosis based on network pharmacology and molecular docking.
Journal: Medicine
Published: November 10, 2020
Tangshen Formula Attenuates Diabetic Kidney Injury by Imparting Anti-pyroptotic Effects via the TXNIP-NLRP3-GSDMD Axis.
Journal: Frontiers in pharmacology
Published: October 30, 2020
Last Updated: 09/26/2026